208 related articles for article (PubMed ID: 36870998)
1. Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches.
El-Shehawy AA; Elmetwalli A; El-Far AH; Mosallam SAE; Salama AF; Babalghith AO; Mahmoud MA; Mohany H; Gaber M; El-Sewedy T
BMC Complement Med Ther; 2023 Mar; 23(1):69. PubMed ID: 36870998
[TBL] [Abstract][Full Text] [Related]
2. Diarylheptanoids/sorafenib as a potential anticancer combination against hepatocellular carcinoma: the p53/MMP9 axis of action.
Elmetwalli A; Diab T; Albalawi AN; El-Naggar SA; El-Far AH; Ghedan AR; Alamri ES; Salama AF
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2501-2517. PubMed ID: 37145126
[TBL] [Abstract][Full Text] [Related]
3. Reverse Screening Bioinformatics Approach to Identify Potential Anti Breast Cancer Targets Using Thymoquinone from Neutraceuticals Black Cumin Oil.
Sundaravadivelu S; Raj SK; Kumar BS; Arumugamand P; Ragunathan PP
Anticancer Agents Med Chem; 2019; 19(5):599-609. PubMed ID: 30678630
[TBL] [Abstract][Full Text] [Related]
4. Regressions of Breast Carcinoma Syngraft Following Treatment with Piperine in Combination with Thymoquinone.
Talib WH
Sci Pharm; 2017 Jul; 85(3):. PubMed ID: 28671634
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone anticancer activity is enhanced when combined with royal jelly in human breast cancer.
Moubarak MM; Chanouha N; Abou Ibrahim N; Khalife H; Gali-Muhtasib H
World J Clin Oncol; 2021 May; 12(5):342-354. PubMed ID: 34131566
[TBL] [Abstract][Full Text] [Related]
6. Rumex vesicarius L. boosts the effectiveness of sorafenib in triple-negative breast cancer by downregulating BCl2, mTOR, and JNK, and upregulating p21 expression.
Ghanem A; Ali MA; Elkady MA; Abdel Mageed SS; El Hassab MA; El-Ashrey MK; Mohammed OA; Doghish AS
Pathol Res Pract; 2023 Oct; 250():154807. PubMed ID: 37696244
[TBL] [Abstract][Full Text] [Related]
7. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
[TBL] [Abstract][Full Text] [Related]
8. The Potential Role of
Alsanosi S; Sheikh RA; Sonbul S; Altayb HN; Batubara AS; Hosawi S; Al-Sakkaf K; Abdullah O; Omran Z; Alhosin M
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566130
[No Abstract] [Full Text] [Related]
9. Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells.
Khan A; Aldebasi YH; Alsuhaibani SA; Khan MA
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1153-1160. PubMed ID: 31030489
[TBL] [Abstract][Full Text] [Related]
10. Thymoquinone extracted from black seed triggers apoptotic cell death in human colorectal cancer cells via a p53-dependent mechanism.
Gali-Muhtasib H; Diab-Assaf M; Boltze C; Al-Hmaira J; Hartig R; Roessner A; Schneider-Stock R
Int J Oncol; 2004 Oct; 25(4):857-66. PubMed ID: 15375533
[TBL] [Abstract][Full Text] [Related]
11. Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects.
Romito I; Porru M; Braghini MR; Pompili L; Panera N; Crudele A; Gnani D; De Stefanis C; Scarsella M; Pomella S; Levi Mortera S; de Billy E; Conti AL; Marzano V; Putignani L; Vinciguerra M; Balsano C; Pastore A; Rota R; Tartaglia M; Leonetti C; Alisi A
J Exp Clin Cancer Res; 2021 Nov; 40(1):364. PubMed ID: 34784956
[TBL] [Abstract][Full Text] [Related]
12. Modulation of gene expression by thymoquinone conjugated zinc oxide nanoparticles arrested cell cycle, DNA damage and increased apoptosis in triple negative breast cancer cell line MDA-MB-231.
Sjs B; K K; A P; P H; B SR; S S
Drug Dev Ind Pharm; 2021 Dec; 47(12):1943-1951. PubMed ID: 35510706
[TBL] [Abstract][Full Text] [Related]
13. Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid.
Yurdacan B; Egeli U; Guney Eskiler G; Eryilmaz IE; Cecener G; Tunca B
J Pharm Pharmacol; 2019 Jul; 71(7):1119-1132. PubMed ID: 31025377
[TBL] [Abstract][Full Text] [Related]
14. Black pepper and piperine induce anticancer effects on leukemia cell line.
Banerjee S; Katiyar P; Kumar V; Saini SS; Varshney R; Krishnan V; Sircar D; Roy P
Toxicol Res (Camb); 2021 Mar; 10(2):169-182. PubMed ID: 33884168
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone Inhibits Growth of Acute Myeloid Leukemia Cells through Reversal
Al-Rawashde FA; Johan MF; Taib WRW; Ismail I; Johari SATT; Almajali B; Al-Wajeeh AS; Nazari Vishkaei M; Al-Jamal HAN
Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959687
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis.
Ashour AE; Abd-Allah AR; Korashy HM; Attia SM; Alzahrani AZ; Saquib Q; Bakheet SA; Abdel-Hamied HE; Jamal S; Rishi AK
Mol Cell Biochem; 2014 Apr; 389(1-2):85-98. PubMed ID: 24399465
[TBL] [Abstract][Full Text] [Related]
17. Induction of Anti-Proliferative and Apoptotic Effects of Sorafenib Using miR-27a Inhibitor in Hepatocellular Carcinoma Cell Lines.
Abdel Wahab AHA; Ayad EG; Abdulla MS; Sharada HM; Ashmawy AM
Asian Pac J Cancer Prev; 2021 Sep; 22(9):2951-2958. PubMed ID: 34582667
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Pluronic F68 and F127 Nanocarrier on Physicochemical Properties,
Shaarani S; Hamid SS; Mohd Kaus NH
Pharmacognosy Res; 2017; 9(1):12-20. PubMed ID: 28250648
[TBL] [Abstract][Full Text] [Related]
20. Insights into the molecular interactions of thymoquinone with histone deacetylase: evaluation of the therapeutic intervention potential against breast cancer.
Parbin S; Shilpi A; Kar S; Pradhan N; Sengupta D; Deb M; Rath SK; Patra SK
Mol Biosyst; 2016 Jan; 12(1):48-58. PubMed ID: 26540192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
